Know Cancer

or
forgot password

INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Cancer

Thank you

Trial Information

INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer


Chart Review to describe the clinical outcomes in patients pancreatic cancer treated with
combination of irinotecan, oxaliplatin and cetuximab.


Inclusion Criteria:



Patients with unresectable/metastatic pancreatic cancer treated in the UNM Cancer Research
and Treatment Center.

Exclusion Criteria:

Not specified.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Principal Investigator

Fa-Chyi Lee, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of New Mexico

Authority:

United States: Institutional Review Board

Study ID:

INST 0603C

NCT ID:

NCT00322712

Start Date:

February 2006

Completion Date:

February 2011

Related Keywords:

  • Pancreatic Cancer
  • Pancreatic Neoplasms

Name

Location

University of New MexicoAlbuquerque, New Mexico  87131